Literature DB >> 30664951

Oligo-astrocytoma in LZTR1-related Noonan syndrome.

Adeline Jacquinet1, Adeline Bonnard2, Yline Capri2, Didier Martin3, Bernard Sadzot4, Elettra Bianchi5, Laurent Servais6, Jean-Paul Sacré6, Hélène Cavé7, Alain Verloes8.   

Abstract

Mutations in LZTR1, already known to be causal in familial schwannomatosis type 2, have been recently involved in a small proportion of patients with autosomal dominant and autosomal recessive Noonan syndrome. LZTR1 is also a driver gene in non syndromal glioblastoma. We report a 26-year-old patient with typical Noonan syndrome, and the dominantly transmitted c.850C > T (p.(Arg284Cys)) variant in LZTR1. An oligoastrocytoma was diagnosed in the patient at the age of 22 years; recurrence of the tumor occurred at age 26, as a ganglioblastoma. The patient had been transiently treated with growth hormone between ages 15 and 17. Considering the implication of LZTR1 in sporadic tumors of the nervous system, we hypothesize that gliomas are a possible complication of LZTR1-related Noonan syndrome. This report also supports a possible link between occurrence of a cerebral tumor in Noonan syndrome and a previous treatment with growth hormone.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Glioma; Growth hormone therapy; LZTR1; Noonan syndrome

Year:  2019        PMID: 30664951     DOI: 10.1016/j.ejmg.2019.01.007

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  5 in total

Review 1.  LZTR1 molecular genetic overlap with clinical implications for Noonan syndrome and schwannomatosis.

Authors:  Kirsten M Farncombe; Emily Thain; Carolina Barnett-Tapia; Hamid Sadeghian; Raymond H Kim
Journal:  BMC Med Genomics       Date:  2022-07-15       Impact factor: 3.622

2.  Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients.

Authors:  Donatella Bianchessi; Maria Cristina Ibba; Veronica Saletti; Stefania Blasa; Tiziana Langella; Rosina Paterra; Giulia Anna Cagnoli; Giulia Melloni; Giulietta Scuvera; Federica Natacci; Claudia Cesaretti; Gaetano Finocchiaro; Marica Eoli
Journal:  Genes (Basel)       Date:  2020-06-19       Impact factor: 4.096

Review 3.  Cracking the Monoubiquitin Code of Genetic Diseases.

Authors:  Raj Nayan Sewduth; Maria Francesca Baietti; Anna A Sablina
Journal:  Int J Mol Sci       Date:  2020-04-25       Impact factor: 5.923

Review 4.  Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.

Authors:  Jovanna Dahlgren; Cees Noordam
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

Review 5.  Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.

Authors:  Stefano Stagi; Vittorio Ferrari; Marta Ferrari; Manuela Priolo; Marco Tartaglia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.